全文获取类型
收费全文 | 4993篇 |
免费 | 267篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 165篇 |
妇产科学 | 16篇 |
基础医学 | 144篇 |
口腔科学 | 2篇 |
临床医学 | 931篇 |
内科学 | 2628篇 |
皮肤病学 | 1篇 |
神经病学 | 28篇 |
特种医学 | 106篇 |
外科学 | 777篇 |
综合类 | 329篇 |
预防医学 | 50篇 |
眼科学 | 2篇 |
药学 | 78篇 |
2篇 | |
中国医学 | 31篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 137篇 |
2022年 | 201篇 |
2021年 | 369篇 |
2020年 | 291篇 |
2019年 | 289篇 |
2018年 | 262篇 |
2017年 | 127篇 |
2016年 | 98篇 |
2015年 | 162篇 |
2014年 | 355篇 |
2013年 | 286篇 |
2012年 | 166篇 |
2011年 | 216篇 |
2010年 | 169篇 |
2009年 | 183篇 |
2008年 | 200篇 |
2007年 | 176篇 |
2006年 | 181篇 |
2005年 | 126篇 |
2004年 | 121篇 |
2003年 | 95篇 |
2002年 | 101篇 |
2001年 | 86篇 |
2000年 | 102篇 |
1999年 | 74篇 |
1998年 | 68篇 |
1997年 | 82篇 |
1996年 | 55篇 |
1995年 | 73篇 |
1994年 | 68篇 |
1993年 | 55篇 |
1992年 | 51篇 |
1991年 | 37篇 |
1990年 | 32篇 |
1989年 | 22篇 |
1988年 | 19篇 |
1987年 | 26篇 |
1986年 | 17篇 |
1985年 | 16篇 |
1984年 | 21篇 |
1983年 | 17篇 |
1982年 | 19篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1976年 | 7篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1973年 | 2篇 |
排序方式: 共有5297条查询结果,搜索用时 15 毫秒
1.
《The Journal of thoracic and cardiovascular surgery》2023,165(2):622-629.e2
ObjectiveDeterioration of the native aortic valve function by a late progression of rheumatic disease is not infrequent in patients who underwent rheumatic mitral valve surgery; however, this phenomenon has not been clearly quantified.MethodsA total of 1155 consecutive patients (age 52.0 ± 12.9 years; 807 female) who underwent rheumatic mitral valve surgery without concomitant aortic valve surgery from 1997 to 2015 were enrolled. The primary end point was the composite of progression to severe aortic valve dysfunction or a requirement of subsequent aortic valve replacements during follow-up. To determine the risk factors of the primary outcome, we performed the generalized linear mixed model.ResultsThe baseline severities of aortic valve were none to trivial in 880 patients (76.2%), mild in 256 patients (22.2%), and moderate in 19 patients (1.6%). The latest 1062 echocardiographic assessments (91.9%; median, 81.2 postoperative months; interquartile range, 37.3-132.1 months) demonstrated 26 cases (0.33%/patient-year) meeting the primary end point during follow-up. Cumulative incidence of the primary end point at 10 years was 0.4% ± 0.3% and 7.4% ± 2.5% depending on the presence of mild or greater aortic valve dysfunction at baseline (P < .01). In multivariable analyses, aortic valve peak pressure gradient (odds ratio, 1.14; 95% confidence interval, 1.10-1.20), aortic regurgitation degree (mild over none: odds ratio, 3.26; 95% confidence interval, 1.15-9.23), and time (odds ratio, 1.30; 95% confidence interval 1.19-1.41) were significantly associated with the occurrence of the primary end point.ConclusionsProgression of severe aortic valve dysfunction and the need for aortic valve replacement are uncommon in patients undergoing rheumatic mitral valve surgery. However, such events were relatively common among those with mild or greater aortic valve dysfunction at the time of mitral valve surgery. 相似文献
2.
3.
4.
《Indian heart journal》2022,74(5):375-381
IntroductionThe female gender is a risk factor for idiopathic pulmonary arterial hypertension. However, it is unknown whether females with rheumatic mitral valve disease are more predisposed to develop pulmonary hypertension compared to males.AimWe aimed to investigate whether there was a difference in genotypic distribution of endothelin-1 (ET-1) and endothelin receptor A (ETA) genes between female and male patients of pulmonary hypertension associated with rheumatic mitral valve disease (PH-MVD).MethodsWe compared prevalence of ET-1 gene (Lys198Asn) and ETA gene (His323His) polymorphisms according to gender in 123 PH-MVD subjects and 123 healthy controls.ResultsThe presence of mutant Asn/Asn and either mutant Asn/Asn or heterozygous Lys/Asn genotypes of Lys198Asn polymorphism when compared to Lys/Lys in females showed significant association with higher risk (odds ratio [OR] 4.5; p =0.007 and OR 2.39; p =0.02, respectively). The presence of heterozygous C/T and either mutant T/T or heterozygous C/T genotypes of His323His polymorphism when compared to wild C/C genotype in females showed a significant association with higher risk (OR 1.96; p =0.047 and OR 2.26; p =0.01, respectively). No significant difference was seen in genotypic frequencies in males between PH-MVD subjects and controls. Logistic regression analysis showed that mutant genotype Asn/Asn (p =0.007) and heterozygous genotype Lys/Asn of Lys198Asn polymorphism (p =0.018) were independent predictors of development of PH in females.ConclusionsET-1 and ETA gene polymorphisms were more prevalent in females than males in PH-MVD signifying that females with rheumatic heart disease may be more susceptible to develop PH. 相似文献
5.
6.
7.
8.
目的:探讨非瓣膜性心房颤动(NVAF)合并重度三尖瓣反流(TR)患者的临床特征及危险因素。方法:连续入选2016年1月至2019年12月就诊于我院的290例合并TR的NVAF患者,87例NVAF合并重度TR患者为重度TR组,男性35例,平均年龄(73.5±9.0)岁;203例NVAF合并轻-中度TR患者作为对照组,男性114例,平均年龄(66.2±10.9)岁。比较两组的临床特征,采用Logistics回归分析评估重度TR的危险因素。结果:290例NVAF患者中,30.0%合并重度TR,41.0%合并中度TR,29.0%合并轻度TR。与对照组相比,重度TR组年龄大[(73.5±9.0)岁vs(.66.2±10.9)岁]、心房颤动病程长[4.5(2.0,10.0)年vs.3.0(2.0,7.0)年]、心功能差、持续性心房颤动(96.6%vs.73.4%)及女性(59.8%vs.43.8%)比例高,同时心房扩大、肺动脉压升高及二尖瓣反流更明显(P均<0.05)。Logistics多因素回归分析显示,重度TR与年龄(OR=1.060,95%CI:1.020~1.102)、女性(OR=4.727,95%CI:1.977~11.306)、持续性心房颤动(OR=6.873,95%CI:1.419~33.297)、右心房左右径(OR=1.202,95%CI:1.117~1.293)相关(P均<0.05)。右心房左右径≥45.5 mm可预测重度TR,诊断敏感度为0.712,特异度为0.697;ROC曲线下面积为0.763(95%CI:0.696~0.831,P<0.001)。结论:NVAF合并重度TR的危险因素包括老年、女性、持续性心房颤动、右心房左右径扩大。 相似文献
9.
《The Annals of thoracic surgery》2023,115(1):88-95
BackgroundRecent guidelines for the treatment of moderate or severe ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed. This study assessed the real-world impact of changing guidelines on the management of IMR during CABG over time. We hypothesized that the utilization of mitral valve repair for IMR would decrease over time, whereas mitral valve replacement for severe IMR would increase.MethodsPatients undergoing CABG in a statewide collaborative database (2011-2020) were stratified by severity of IMR. Trends in mitral valve repair or replacement were evaluated. To account for differences of the patients, propensity score–matched analyses were used to compare patients with and without mitral intervention.ResultsA total of 11,676 patients met inclusion criteria, including 1355 (11.6%) with moderate IMR and 390 (3.3%) with severe IMR. The proportion of patients undergoing mitral intervention for moderate IMR decreased over time (2011, 17.7%; 2020, 7.5%; Ptrend = .001), whereas mitral replacement for severe IMR remained stable (2011, 11.1%; 2020, 13.3%; Ptrend = .14). Major morbidity was higher for patients with moderate IMR who underwent mitral intervention (29.1% vs 19.9%; P = .005). In a propensity analysis of 249 well-matched pairs, there was no difference in major morbidity (29.3% with mitral intervention vs 23.7% without; P = .16) or operative mortality (1.2% vs 2.4%; P = .5).ConclusionsConsistent with recent guideline updates, patients with moderate IMR were less likely to undergo mitral repair. However, the rate of replacement for severe IMR did not change. Mitral intervention during CABG did not increase operative mortality or morbidity. 相似文献
10.
《Heart, lung & circulation》2022,31(9):e126-e128